latestage

Health

ALS drug pulled from market in Canada, U.S. after failing late-stage clinical trial

Amylyx Pharmaceuticals said Thursday it will withdraw its amyotrophic lateral sclerosis (ALS) drug from the market in Canada and the U.S.…

Read More »
Back to top button